One stage ADM-assisted breast reconstruction, as safe as two stage submuscular implant breast reconstruction
Association of Breast Surgery ePoster Library. Wilson R. 05/15/17; 166291; P010
Ms. Rebecca Wilson
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Rate & Comment (0)
Introduction
It has been suggested that direct to implant ADM-assisted reconstructions pose a greater risk of post-operative complications than a two-stage procedure but evidence is limited. Our aim was to assess unplanned explantation rates between direct to implant and two-stage procedures in both Strattice™-assisted and submuscular reconstructions.
Methods
Retrospective case note, implant database and theatre log review of consecutive immediate implant-based reconstructions performed from January 2009 to December 2015.
Results
373 patients underwent 375 Strattice™-assisted and 135 submuscular reconstructions.
Of the Strattice™-assisted reconstructions, 285 (76%) were direct to implant, 72 (19%) were Becker implants and 18 (5%) were two-stage procedures. Of the submuscular reconstructions 3 (2%) were direct to implant, 14 (10%) were Becker implants and 118 (88%) were two-stage procedures.
Unplanned explantation rates as a complication of the primary surgery were 4.9% in the Strattice-assisted direct to implant reconstructions compared to 6.8% in the two-stage submuscular reconstructions.
In the Strattice™-assisted group, total unplanned explantation was 6.4%, with 15 due to infection and 9 wound breakdown. Of the Strattice-assisted explants, 14 (5%) were direct-to-implant, 7 (10%) were Becker implants and 3 (17%) were two-stage.
In the submuscular group, total unplanned explantation was 8.9%, with 7 due to infection and 5 wound breakdown. Of the submuscular explants, 1 (33%) was direct to implant, 3 (21%) were Becker implants and 8 (7%) were two-stage.
Conclusions
A one stage procedure with ADM appears as safe, with similar proportion of explantations, as a two-stage submuscular procedure, with the benefits of a single operative stay
It has been suggested that direct to implant ADM-assisted reconstructions pose a greater risk of post-operative complications than a two-stage procedure but evidence is limited. Our aim was to assess unplanned explantation rates between direct to implant and two-stage procedures in both Strattice™-assisted and submuscular reconstructions.
Methods
Retrospective case note, implant database and theatre log review of consecutive immediate implant-based reconstructions performed from January 2009 to December 2015.
Results
373 patients underwent 375 Strattice™-assisted and 135 submuscular reconstructions.
Of the Strattice™-assisted reconstructions, 285 (76%) were direct to implant, 72 (19%) were Becker implants and 18 (5%) were two-stage procedures. Of the submuscular reconstructions 3 (2%) were direct to implant, 14 (10%) were Becker implants and 118 (88%) were two-stage procedures.
Unplanned explantation rates as a complication of the primary surgery were 4.9% in the Strattice-assisted direct to implant reconstructions compared to 6.8% in the two-stage submuscular reconstructions.
In the Strattice™-assisted group, total unplanned explantation was 6.4%, with 15 due to infection and 9 wound breakdown. Of the Strattice-assisted explants, 14 (5%) were direct-to-implant, 7 (10%) were Becker implants and 3 (17%) were two-stage.
In the submuscular group, total unplanned explantation was 8.9%, with 7 due to infection and 5 wound breakdown. Of the submuscular explants, 1 (33%) was direct to implant, 3 (21%) were Becker implants and 8 (7%) were two-stage.
Conclusions
A one stage procedure with ADM appears as safe, with similar proportion of explantations, as a two-stage submuscular procedure, with the benefits of a single operative stay
Introduction
It has been suggested that direct to implant ADM-assisted reconstructions pose a greater risk of post-operative complications than a two-stage procedure but evidence is limited. Our aim was to assess unplanned explantation rates between direct to implant and two-stage procedures in both Strattice™-assisted and submuscular reconstructions.
Methods
Retrospective case note, implant database and theatre log review of consecutive immediate implant-based reconstructions performed from January 2009 to December 2015.
Results
373 patients underwent 375 Strattice™-assisted and 135 submuscular reconstructions.
Of the Strattice™-assisted reconstructions, 285 (76%) were direct to implant, 72 (19%) were Becker implants and 18 (5%) were two-stage procedures. Of the submuscular reconstructions 3 (2%) were direct to implant, 14 (10%) were Becker implants and 118 (88%) were two-stage procedures.
Unplanned explantation rates as a complication of the primary surgery were 4.9% in the Strattice-assisted direct to implant reconstructions compared to 6.8% in the two-stage submuscular reconstructions.
In the Strattice™-assisted group, total unplanned explantation was 6.4%, with 15 due to infection and 9 wound breakdown. Of the Strattice-assisted explants, 14 (5%) were direct-to-implant, 7 (10%) were Becker implants and 3 (17%) were two-stage.
In the submuscular group, total unplanned explantation was 8.9%, with 7 due to infection and 5 wound breakdown. Of the submuscular explants, 1 (33%) was direct to implant, 3 (21%) were Becker implants and 8 (7%) were two-stage.
Conclusions
A one stage procedure with ADM appears as safe, with similar proportion of explantations, as a two-stage submuscular procedure, with the benefits of a single operative stay
It has been suggested that direct to implant ADM-assisted reconstructions pose a greater risk of post-operative complications than a two-stage procedure but evidence is limited. Our aim was to assess unplanned explantation rates between direct to implant and two-stage procedures in both Strattice™-assisted and submuscular reconstructions.
Methods
Retrospective case note, implant database and theatre log review of consecutive immediate implant-based reconstructions performed from January 2009 to December 2015.
Results
373 patients underwent 375 Strattice™-assisted and 135 submuscular reconstructions.
Of the Strattice™-assisted reconstructions, 285 (76%) were direct to implant, 72 (19%) were Becker implants and 18 (5%) were two-stage procedures. Of the submuscular reconstructions 3 (2%) were direct to implant, 14 (10%) were Becker implants and 118 (88%) were two-stage procedures.
Unplanned explantation rates as a complication of the primary surgery were 4.9% in the Strattice-assisted direct to implant reconstructions compared to 6.8% in the two-stage submuscular reconstructions.
In the Strattice™-assisted group, total unplanned explantation was 6.4%, with 15 due to infection and 9 wound breakdown. Of the Strattice-assisted explants, 14 (5%) were direct-to-implant, 7 (10%) were Becker implants and 3 (17%) were two-stage.
In the submuscular group, total unplanned explantation was 8.9%, with 7 due to infection and 5 wound breakdown. Of the submuscular explants, 1 (33%) was direct to implant, 3 (21%) were Becker implants and 8 (7%) were two-stage.
Conclusions
A one stage procedure with ADM appears as safe, with similar proportion of explantations, as a two-stage submuscular procedure, with the benefits of a single operative stay
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}